Hedychium spicatum (Spiked Ginger Lily / Kapur Kachri): A Comprehensive Reference
1. Identity, Taxonomy, and Natural Source
Botanical Classification and Nomenclature
Hedychium spicatum Buch.-Ham. ex D.Don, commonly known as spiked ginger lily or Kapur Kachri, is a rhizomatous perennial herb from the family Zingiberaceae, widely distributed in the Himalayan regions and valued for its medicinal, aromatic, and ornamental attributes. It is also commonly known as spiked ginger lily or perfume ginger. In Sanskrit, the species is also known as Palashi, Shatgrantha, Subratha, Gandhmulika, Gandharika, Gandhvadhu, and Prathupalashika, while in Ayurveda it is primarily called "Shati." The plant is commonly known as Kuchri in Hindi.
Geographic Distribution and Habitat
Hedychium spicatum is a plant species native to China (Guizhou, Sichuan, Tibet, Yunnan), the Himalayas, Myanmar, and Thailand. It is an exclusively Himalayan species distributed wildly in Himachal Pradesh, Uttarakhand, Nepal, and Sikkim. It is endemic to the Himalayan belt, spanning from northern India (Uttarakhand, Himachal Pradesh, Jammu & Kashmir, Arunachal Pradesh) to Nepal, Bhutan, Myanmar, Tibet, and southwestern China, with extensions to Thailand and Vietnam. It inhabits subtropical to temperate zones at altitudes of 1500–2700 m, favoring moist, shady forest understories, grasslands, and rocky slopes. Preferred conditions include well-drained loamy soils with pH 5.5–7.0, annual precipitation of 1000–2000 mm, and temperatures ranging from 5–25°C.
Botanical Description
Hedychium spicatum is an annual-perennial, rhizomatous, erect herb, with a pseudostem that is leafy and 5–150 cm high. Leaves are broadly ovate-lanceolate, 30–60 cm × 10–20 cm, acuminate, glabrous above, and sparsely pubescent beneath. Hedychium spicatum is a small, hardy perennial that grows to around 1 m (3 ft 3 in), with green leaves and large orange and white flowers. The chromosome number in H. spicatum has been found to be 34 (n=17). Histological studies of the species revealed that the rhizome consists of a delicate parenchyma; most of the cells are loaded with starch grains, and a few contain a yellowish resin and essential oil.
Commercial Forms and Preparations
The species is used in medicines, food, cosmetics, and perfumery industries. Powders, syrups, and tablets made from rhizomes are common Ayurvedic preparations. Oils have also been used in cosmetics such as hair oil, face powder, and incense. The powdered form of dried rhizomes is used as a herbal festival color, and the rhizomes are used to provide aroma to tobacco. Rhizomes are used in making the well-known tonic and food supplement called Chyawanprash. The essential oil (commercially known as "Kapur Kachri Oil") extracted from the rhizomes is used industrially and has demonstrated antimicrobial activity against both Gram-positive and Gram-negative bacteria.
2. Traditional and Historical Use
Ayurveda (India)
In Ayurveda and the Charaka Samhita, H. spicatum is mentioned to have Kaphavataghna and Shwasahara mahakashaya dravya properties — meaning the plant can balance both Kapha and Vata doshas and has the potency to treat cough and other respiratory problems. According to Ayurveda, it acts as a pain reliever (Vedansthapana), an odour neutralizer (dur-gandhanashana), an appetite stimulant (deepana), a blood purifier (rakthashodhaka), an antipyretic (jwaraghna), a stimulant (uttejaka), and a hair conditioner (keshya). The Indian medicinal system (Ayurveda) described the species as having pungent, light, bitter, strong, and heating properties.
Specific Ayurvedic indications include: Mukhavairasya (bad breath), Maladaurgandhya (bad-smelling sweat, urine, and feces), Kasa (cough and cold), Vrana (ulcers and wounds), Shwasa (asthma and chronic respiratory disorders), Shoola (abdominal colic pain), Hidhma (hiccups), Jwara (fever), and Rakta shodhaka (blood purification).
Among the many Ayurvedic formulations of H. spicatum, the most acclaimed is Bharangyadi, a polyherbal formulation also containing Clerodendrum serratum Moon and Inula racemosa Hook.f.
The species has a profuse traditional history of utilization in various traditional medication systems, with 175 known Tibetan formulations and 233 formulations in Indian medicine.
Tibetan Medicine
In the Tibetan system of medicine, this species is considered a potential source for respiratory treatment. One of the widely used polyherbal Tibetan powdered formulations named PADMA 28 consists of Hedychium spicatum Buch.-Ham. ex Sm. rhizomes (10 mg), which is used for chronic inflammatory disorders and shows potent action against infection of the respiratory tract. PADMA-28, a traditional Tibetan medicine, is used for peripheral vascular disease, persistent inflammatory disorders, and occlusive disease, and has shown encouraging outcomes in chronic atherosclerosis, intermittent claudication, and hepatitis.
Traditional Chinese Medicine, Unani, and Folk Systems
The species is also an ingredient of some traditional Chinese medicine (TCM), traditional Tibetan medicine, and Unani medicine. The herb forms an important part of various polyherbal formulations cited in various classical texts of Chinese, Tibetan, Indian, and Unani origin. Rhizomes of H. spicatum are used in stomachache, indigestion, loss of appetite, and constipation by Raji communities in far western Nepal. Additionally, it is also used in the treatment of dyspepsia, nausea and pain, tuberculosis, asthma, foul breath, bronchitis, hiccoughs, blood disease, and poor circulation.
Traditional Preparations
The powder and decoction of the rhizome are used for a variety of conditions. It is used in various Ayurvedic herbal formulations for treating digestion problems, problems related to the respiratory system, hair loss, joint pain, hiccups, and for maintaining cardiac health. The formulations usually contain the rhizomes of the plant and can be formulated in tablet, powder, or syrup form. The roots and leaves of this plant are used in Tibetan medicines.
3. Key Constituents and Active Compounds
Essential Oil Composition
The rhizome contains about 4% essential oil containing a variety of terpenoids (monoterpenoids, sesquiterpenoids, and diterpenoids) with 1,8-cineole, camphene, sabinene, β-pinene, myrcene, and α-phellandrene as major constituents. Among the identified compounds, 1,8-cineole is present in large quantities — around 27–75% — and is found to be the major compound of essential oil. In one study analyzing essential oils from six different natural habitats at different altitudes in Uttarakhand, India, twenty compounds were identified, accounting for 87.4–98.5% of the essential oils, with 1,8-cineole (33.4–41.9%), α-terpinene (39.6%), camphor (31.4%), and linalool (29.9%) being the prevalent major constituents.
The essential oil obtained from the rhizome of the species amounts to 0.06 to 6.12% yield, with 1,8-cineole (27–75%) as the major component. α- and β-Pinene, linalool, 10-epi-γ-eudesmol, and β-selinene were also reported from the essential oil of the rhizome in significant quantities. Additionally, (E)-caryophyllene, spathulenol, 1-epi-cubenol, 4-terpineol, borneol, camphene, camphor, caryophyllene oxide, germacrene D-4-ol, hedycaryol, limonene, sabinene, terpine-4-ol, α-cadinol, α-eudesmol, α-humulene, α-selinene, β-eudesmol, β-farnesene, β-himachalene, β-myrcene, β-phellandrene, γ-muurolene, p-cymene, and δ-cadinene have also been reported in the essential oil.
Chemotypic variation is observed in the essential oil, influenced by altitude, soil, and season, with higher essential oil content in high-altitude accessions. The essential oil of H. spicatum obtained from different locations of the Himalayan region has shown great variation in its components, especially in 1,8-cineole, terpine-4-ol, 10-epi-γ-eudesmol, eudesmol, cubenol, spathulenol, and α-cadinol, which influenced its antioxidant, antimicrobial, and cytotoxic properties.
Non-Volatile (Fixed) Secondary Metabolites
The phytochemical diversity of Hedychium spicatum is concentrated in its rhizomes, with over 137 compounds identified through GC-MS, HPLC, and NMR analyses. Numerous primary and secondary metabolites have been identified in Hedychium spicatum, including saponins, alkaloids, resins, carbohydrates, protein, steroids, tannins, starch, glycosides, albumin, phytosterols, and flavonoids.
Labdane diterpenes are among the most pharmacologically significant non-volatile compounds. Chemical constituents from the rhizomes of H. spicatum led to the isolation of two new labdane-type diterpenes characterized as 7-hydroxy hedichinal and spicatanoic acid, and six known compounds: yunnacoronarin D, coronarin E, 8(12)-drimene, 4-methoxy ethyl cinnamate, ethyl cinnamate, and chrysin. Chemical constituents present in hexane, chloroform, ethyl acetate, and methanolic extract of Hedychium spicatum, namely Hedychenone, Hedychilactone D, Coronarin D, Coronarin E, 9-Hydroxy Hedychenone, 7-Hydroxy Hedychenone, Yunnacoronarin A, and Coronarin D methyl ether and ethyl ether (diterpenes and diterpenoids), have been identified as having anti-inflammatory, anti-allergic, antibacterial, and cytotoxic effects.
Flavonoids and phenolic acids are also prominent. Significant phenolic and flavonoid compounds include quercetin, chrysin, teptochrysin, and ethyl-trans-p-methoxy cinnamate. The plant also contains polyphenols, contributing to its antioxidant properties.
Phytosterols: Beta-sitosterol is a prominent sterol identified in the rhizome, and it has been associated with antidiabetic activity. The rhizome has also yielded sitosterol and its glucoside, as well as the furanoid diterpene hedychenone and 7-hydroxyhedychenone.
4. Mechanisms of Action
Anti-inflammatory Mechanisms
Related labdane diterpenoids have been shown to reduce the production of pro-inflammatory mediators such as TNF-α and IL-6 at both transcriptional and translational levels in LPS-stimulated murine macrophages. Many labdane-type diterpenes function as inhibitors of inflammatory cytokine production through repression of NF-κB. Diterpenes and diterpenoids, including hedychenone, hedychilactone D, coronarin D, and coronarin D ethyl ether, may have future potential as anti-inflammatories and may be effective against inflammatory mediators and precursors.
Anticancer and Cytotoxic Mechanisms
H. spicatum essential oil (HSEO) was tested for in vitro cytotoxic activity against cancerous (PC-3, HCT-116, and A-549) and normal (3T3-L1) cells, with HSEO being most selective for prostate cancer cells (PC-3) over non-tumorigenic fibroblast (3T3-L1) cells. HSEO treatment inhibited the colony formation ability of PC-3 cells. HSEO treatment caused apoptotic cell death and cell cycle arrest at G2/M and S phases in PC-3 cells. HSEO induced apoptosis via intracellular ROS accumulation, mitochondria depolarization, and increased caspase-3, 8, and 9 levels in PC-3 cells. Additionally, HSEO treatment led to a decrease of Bcl-2 and Bcl-xL and an increase of Bax and Bak protein levels.
Antidiabetic Mechanisms
Antidiabetic potential involves α-glucosidase inhibition (IC₅₀ 50–100 µg/mL) and improved glucose tolerance in streptozotocin-induced diabetic rats.
Hepatoprotective Mechanisms
Diterpenes protect hepatocytes from toxins, normalizing SGOT/SGPT in CCl₄ models. Alcohol and ethyl acetate extracts of dried rhizomes of H. spicatum administered in albino rats showed significant hepatoprotective activity, with a decrease in the serum levels of glutamate oxaloacetate transaminase (SGOT) and glutamate pyruvate transaminase (SGPT) observed.
5. Scientific Evidence by Area of Use
5.1 Anti-inflammatory and Analgesic Activity
Hedychium spicatum exhibits significant pharmacological properties, including anti-inflammatory and analgesic effects validated through studies. Extracts and individual compounds were isolated from Hedychium spicatum and Hedychium coronarium, and both species were studied in vitro for anti-inflammatory, antifungal, antimicrobial, and cytotoxic qualities. Tandon et al. (1997) reported that treatment with aqueous and ethanol extracts of Hedychium spicatum at a dose of 1000 mg/kg body weight produced significant gastric ulcer protection against histamine-induced gastric ulcer in guinea pigs. The dried rhizome of H. spicatum was evaluated for anti-histaminic and ulcer-protective activities in guinea pigs and showed significant activity.
Evidence strength: All anti-inflammatory and analgesic evidence is preclinical (animal and in vitro). No clinical trials in humans isolating H. spicatum alone for these endpoints have been identified in the peer-reviewed literature.
5.2 Respiratory and Anti-asthmatic Activity
The plant has been extensively used in ethnomedicinal systems such as Ayurveda, Unani, and traditional folk medicine for the management of inflammatory disorders, pain, asthma, bronchitis, gastrointestinal issues, and hematological conditions. Extracts have been shown to relax bronchial smooth muscle in guinea pigs, alleviating asthma via β-sitosterol. In the Tibetan system of medicine, H. spicatum is considered a potential source for respiratory treatment and forms part of PADMA 28, a polyherbal formulation (containing 10 mg of the rhizome) used for chronic inflammatory disorders that shows potent action against infection of the respiratory tract.
A clinical trial of Hedychium spicatum in tropical pulmonary eosinophilia was reported by Sahu (cited in Rawat et al., 2018, as published in the Journal of the Nepal Pharmacist Association). This represents limited, older clinical evidence. PADMA 28 — the multi-compound Tibetan herbal remedy that includes H. spicatum rhizome — is documented to possess anti-inflammatory, antioxidant, antimicrobial, angioprotective, and wound-healing properties, but clinical studies are attributable to the complex formula, not H. spicatum alone.
Evidence strength: Animal (guinea pig) and preclinical data support bronchospasmolytic effects; limited clinical data for H. spicatum in isolation.
5.3 Anticancer / Cytotoxic Activity
Hedychium spicatum essential oils have been found to contain dominant volatile constituents like 1,8-cineole, eudesmol, cubenol, spathulenol, and α-cadinol, which displayed anti-tumor effects against lung, colon, breast, head and neck, and cervical cancer cells. Hedychium spicatum essential oil, mainly composed of β-pinene and eucalyptol, inhibited the viability of PC-3 prostate cancer cells in a dose-dependent manner with an IC₅₀ value of 21.88 µg/mL. It also induced apoptotic cell death, cell cycle arrest at the G2/M and S phases, intracellular ROS accumulation, mitochondria depolarization, and increased caspase-3, -8, and -9 levels. Coronarin D possesses antibacterial, antifungal, and antitumor activities; isocoronarin D, linalool, and villosin exhibit cytotoxicity toward tumor cell lines.
Evidence strength: All anticancer data is in vitro (cell line studies) and/or in silico. No clinical trials or animal tumor model studies in humans have been reported for H. spicatum alone. This evidence is preliminary and exploratory.
5.4 Hepatoprotective Activity
Alcohol and ethyl acetate extracts of dried rhizomes of H. spicatum administered in albino rats showed significant hepatoprotective activity, with a decrease in the serum levels of glutamate oxaloacetate transaminase (SGOT) and glutamate pyruvate transaminase (SGPT) observed. Diterpenes protect hepatocytes from toxins, normalizing SGOT/SGPT in CCl₄ models. Multiple preclinical studies have confirmed this activity in rat models.
Evidence strength: Animal and in vitro studies only; no human clinical hepatoprotective trials have been identified.
5.5 Antidiabetic Activity
Hedychium spicatum is described as an anti-diabetic herb with a long history of use in the traditional system of medicine. In one preclinical study, the antidiabetic activity of essential oil was studied after extracting the oil from rhizomes using a Clevenger apparatus. The activity was studied in vivo in diabetic male Wistar rats with glibenclamide as the reference drug. After administering the rats with plant oil at 0.3 ml per rat for 14 days, blood samples were collected to check blood glucose level and various renal function parameters, and a histopathological study of the pancreas was conducted for each group. GC-MS analysis revealed that the main component in the oil was 1,8-cineole. Results showed that the oral dose of HSEO reduced blood glucose and urea levels in treated rats in a statistically significant manner. In another rodent study, ethanolic extracts were administered at doses of 100, 300, and 500 mg/kg body weight as test groups, with another group receiving 50% extract of 100 mg/kg combined with 50% of the standard dose, administered orally for 40 days.
Evidence strength: Preclinical (rodent) studies only; no randomized controlled trials in humans have been reported.
5.6 Antimicrobial Activity
Essential oil from the rhizomes (commercially known as "Kapur Kachri Oil") has shown antimicrobial activity against both Gram-positive and Gram-negative bacteria. Preclinical studies demonstrate potent inhibition of inflammatory mediators, free radical scavenging, and antimicrobial efficacy against various pathogens, often comparable to standard drugs.
Evidence strength: In vitro antimicrobial assay data only.
5.7 Antioxidant Activity
The essential oil of H. spicatum obtained from different locations of the Himalayan region has shown great variation in components, which influenced its antioxidant properties. Key bioactive compounds such as flavonoids, terpenoids, essential oils, and phenolic acids have been identified, many of which are associated with anti-inflammatory, antimicrobial, antioxidant, analgesic, and immunomodulatory effects.
Evidence strength: In vitro antioxidant assay data (e.g., DPPH, FRAP); no human clinical evidence.
5.8 Central Nervous System / Sedative Activity
A single study concluded that both the hexane and benzene extracts had a mild CNS-depressant effect. This activity has been listed in reviews as "tranquilizing" or sedative, but the evidence base consists of a very limited number of preclinical investigations.
Evidence strength: Very limited preclinical data; not confirmed in human studies.
5.9 PADMA 28 (Multi-Ingredient Tibetan Formula Containing H. spicatum)
PADMA 28 tablets are a herbal mixture consisting of 22 ingredients, including Hedychium spicatum rhizome (10 mg per tablet), along with other botanicals such as Aegle marmelos, Pimenta dioica, Calendula officinalis, Saussurea lappa, and others. PADMA 28 is a herbal multicompound remedy that originates from traditional Tibetan medicine and has documented anti-inflammatory, antioxidant, antimicrobial, angioprotective, and wound-healing properties. Clinical studies on PADMA 28 as a whole formulation have been conducted in humans for conditions such as peripheral arterial occlusive disease and chronic inflammatory disorders; however, any observed effects cannot be attributed to H. spicatum alone given the complex multi-ingredient nature of the formula.
6. Body Systems and Health Areas Associated with Hedychium spicatum
- Respiratory system: Traditionally widely used in treating asthma, bronchitis, and hiccough.
- Digestive and gastrointestinal system: Rhizomes are used for pain, diarrhoea, nausea, liver problems, vomiting, inflammation, headache, stomachache, and fever.
- Hepatic (liver) system: Preclinical studies show hepatoprotective effects via normalization of liver enzymes.
- Endocrine/metabolic: Associated with antidiabetic use in traditional medicine and demonstrated in animal studies.
- Musculoskeletal and pain: Used as a pain reliever (Vedansthapana) in Ayurveda.
- Immune/inflammatory: Documented NF-κB suppression and cytokine modulation in preclinical models.
- Integumentary (skin and hair): Rhizome is used for the treatment of baldness and skin-related conditions.
- Cardiovascular and circulatory: Reported blood pressure reduction and blood-purifying activity in the traditional literature.
- Central nervous system: Described in traditional systems as a tranquilizer; limited preclinical evidence for CNS-depressant activity.
- Oncology (preclinical): In vitro cytotoxic activity against lung, colon, breast, head and neck, cervical, and prostate cancer cell lines.
7. Dosage Forms and Reported Dosages
Common Ayurvedic preparations include powders, syrups, and tablets made from the rhizomes. The following dosages have been reported in specific scientific studies:
- Aqueous and ethanol extracts at a dose of 1000 mg/kg body weight were used to produce significant gastric ulcer protection against histamine-induced gastric ulcer in guinea pigs (Tandon et al., 1997).
- Ethanolic extracts were administered at doses of 100, 300, and 500 mg/kg body weight in rat antidiabetic studies, with some groups receiving 50% extract at 100 mg/kg combined with 50% of a standard dose, administered orally for 40 days.
- In a rat essential oil antidiabetic study, the plant oil was administered at 0.3 ml per rat for 14 days.
- In the prostate cancer (PC-3) cytotoxicity study, HSEO inhibited PC-3 cell viability in a dose-dependent manner with an IC₅₀ value of 21.88 µg/mL.
- In the PADMA 28 formulation — the Tibetan polyherbal remedy — H. spicatum rhizome contributes 10 mg per tablet.
No standardized human clinical dosage for H. spicatum as an isolated supplement has been established in the peer-reviewed literature. All animal dosages above are from preclinical rodent and guinea pig models and should not be extrapolated to human use.
8. Safety Considerations
General Safety Profile
Hedychium spicatum is generally regarded as safe, with traditional use spanning centuries without reported toxicity. Only a few reports are available on the toxicity of this plant. A single study concluded that both the hexane and benzene extracts had a mild CNS-depressant effect. Despite its promising attributes, toxicity and safety profile data are still limited, particularly in long-term or high-dose usage contexts.
Conservation Status and Supply Concerns
It has been listed as a vulnerable and near-threatened species by the International Union for the Conservation of Nature and Natural Resources (IUCN). The population of H. spicatum has decreased by more than 20% in the past ten years, making it more vulnerable. The species is over-exploited for its rhizomes, which are valued as the source of essential oil and are used in cosmetic and perfumery industries. The species is slow-growing and takes two to three years to reach reproductive maturity. Annual demand for H. spicatum in India alone is approximately 400 tons. The main threat to the species is extensive collection from the wild, and sharp population declines are suspected.
Absence of Human Clinical Safety Data
No published randomized controlled trials or formal pharmacovigilance studies evaluating the safety of H. spicatum preparations in human subjects have been identified in the current peer-reviewed literature. Future research should emphasize clinical trials, mechanistic investigations, standardization of extracts, and sustainable cultivation to mitigate threats and fully exploit its therapeutic potential.
Interactions
No formal drug-interaction studies for Hedychium spicatum in isolation have been published in the peer-reviewed literature reviewed here. Given the mild CNS-depressant activity reported in one preclinical study and the presence of bioactive terpenoids with known pharmacological effects, caution regarding concurrent sedative or anti-inflammatory drug use has been noted by reviewers, though no specific human interaction data exist.
9. Research Gaps and Future Directions
Over 137 publications have investigated H. spicatum, but gaps remain in research on propagation and commercial cultivation. Few pharmacological reports investigating the anticancer activity of Hedychium spicatum essential oil have been reported so far, and the underlying molecular and cellular mechanism of its anticancer activity is still lacking. Terpenoids are hexane-soluble, while hexane-extracted materials are not likely to be used for human intake; suitable green technology such as supercritical fluid extraction and ethanol-based extraction methods may help the extract to become more prominent in human uses. Future research should emphasize clinical trials, mechanistic investigations, standardization of extracts, and sustainable cultivation to mitigate threats and fully exploit therapeutic potential.
References
Go back